Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,874 | Dovepress* | 4,449+ | 217 | 4,666 | |
PubMed Central* | 425 | 198 | 623 | ||
Totals | 4,874 | 415 | 5,289 | ||
*Since 16 November 2021 |
View citations on PubMed Central and Google Scholar